Fundraising Fox

Biotech Investors & VC Firms in United States

563 firms in this list, with a median first check of $500K. 45 of them lead rounds. Generated from verified public data and updated continuously.

Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
60 people
RA Capital
BostonSeed–Late Stage
11 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
17 people
Lerer Hippeau
New YorkSeed–Series B$1M – $5M
20 people
Connecticut Innovations
ConnecticutPre-Seed–Growth$500K – $2M
11 people
Playground Global
Palo AltoPre-Seed–Series A$1M – $20M
41 people
Lux Capital
New York CitySeries A–Growth$100K – $100M
44 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
13 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage
34 people
Third Rock Ventures
BostonSeed–Series C
64 people
5AM Ventures
BostonSeed–Late Stage$4M
40 people
Deerfield Management Company
New YorkGrowth–Late Stage
62 people
The Innovation Space
WilmingtonPre-Seed–Seed$200K
26 people
Giant Ventures Global Llp
LondonPre-Seed–Late Stage
30 people
Foresite Capital
West HollywoodPre-Seed–Late Stage
Obvious Ventures
San FranciscoPre-Seed–Late Stage
37 people
Advent Life Sciences
LondonSeed–Late Stage
25 people
Prime Movers Lab
JacksonSeed–Series B
28 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
31 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
35 people
US Venture Partners
Menlo ParkSeed–Late Stage$500K – $10M
8 people
Mission Biocapital
San FranciscoPre-Seed–Seed$500K – $500K
20 people
Polaris Partners
BostonSeed–Growth$500K – $5M
31 people
SR One Capital Management
Redwood CitySeed–Series B
25 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.